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Abstract
Purpose Snoring is the primary, most distinguishable symptom of Obstructive Sleep Apnea
(OSA). Increased activation of the sympathetic tone is also consistently identified in adults with
clinically diagnosed OSA. We compared heart rate variability (HRV) in snoring and non-snoring
college-aged subjects to assess any HRV alterations between groups that could potentially
signify an early marker for developing OSA.
Methods 23 male snorers and 7 male non-snorer subjects were studied. The HRV variables in the
R-R heart intervals were compared between the groups via obtaining heart rate from the polar
RS800CX monitor and performing an analysis using an independent sample t-test. All subjects
were of similar age, body composition, and physical fitness.
Results HRV was not significantly reduced in snoring subjects compared to non-snoring
subjects. Age was significantly correlated to pNN50 (r=-0.48, p=0.01), RMSSDLog (r=-0.45,
p=0.01), HFLog (r=-0.49, p=0.01), Log LF/HF Ratio (r=0.53, p=0.00), LFnu (r=0.50, p=0.01),
and HFnu (r=-0.50, p=0.01).
Conclusion HRV alterations of increased sympathetic tone to parasympathetic tone are not
significantly associated with young snorers. Increased age is correlated to elevated imbalance in
HRV, most likely due to sympathetic build up over time as a result of increased progression of
the sleep disorder. The HRV measure may be a useful indicator of diagnosed OSA in middleaged adults, but not a powerful indicator of onset OSA in younger individuals because they are at
too early of a point in potential progression of the disorder to elicit any significant physiological
changes.
Keywords: snoring, heart rate variability, sympathetic tone, obstructive sleep apnea
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Chapter I
Introduction
Obstructive sleep apnea (OSA) is characterized by repetitive cessations or decreases in
ventilation during an individual’s sleep cycle due to intermittent bouts of partial or total collapse
of the pharyngeal airway [1]. The after-effect of the pharyngeal airway blockages is hypoxia and
an inadequate amount of oxygen in the blood flow delivery from the lungs to the cells of the
body. An obstructive apneic episode results from a complete airway obstruction involving a 10
second or greater cessation in respiration. An obstructive hypopnea is defined as a partial
blockage in the pharyngeal airway leading to a periodic decrease in ventilation, rather than a
complete cessation. Bouts of obstructive hypopnea can be just as severe as obstructive apnea in
that ventilation decreases are highly associated with dramatic decreases in oxygen saturation
[32]. Both obstructive episodes occur even with continued ventilation effort of the lungs [1]. An
individual is diagnosed with OSA if they experience an average of five or more episodes of
obstructive apnea or obstructive hypopnea per hour of sleep, along with encountering strong
symptoms of excessive daytime sleepiness (EDS) [32]. EDS is a primary OSA symptom because
it signifies sleep deprivation caused by obstructive apnea disturbances [39].
OSA is the dominant sleep disordered condition in America, affecting an estimated 15
million adults [32]. Due to the high prevalence and the likelihood of the disorder to develop
without being clinically diagnosed, OSA is a major public health concern and it is critical that
substantial measures are taken to identify the disorder. Individuals with OSA suffer from the
stress reaction developed from constant sleep deprival and can face long term physiological
damage as a consequence of the oxygen deprivation during the obstructive apneas and
hypopneas. Along with the severity of the disorder itself, OSA is also associated with a number
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of comorbidities, which produce a greater threat to individual health. OSA has been shown to
significantly increase the risk of cardiovascular diseases, including coronary artery disease,
congestive heart failure, stroke, and atrial fibrillation [12]. In addition, OSA is also related to
metabolic syndrome, hypertension, and diabetes mellitus [2-15].
Snoring, habitual or disruptive, is the most common sign of OSA [18-20]. Habitual and
disruptive snoring cause poor sleep quality as well as major disturbances in sleeping patterns,
often to the extreme extent in which breathing pauses completely [33]. Snoring occurs as a
response to a reduction in airflow to the nose or mouth during sleep due to anatomical factors,
which include incompetent oral muscle tone, space occupying masses, excessive length of the
soft palate and uvula, and an obstructed nasal airway [33]. A relaxed oral muscle tone results in
diminished rigid support in the mouth, which consequently leads to the falling of the tongue and
throat muscles back into the airway creating a blockage in airflow [33]. Space occupying masses,
specifically bulky throat tissue, cause a significant reduction in airflow because a vast amount of
space is compromised in the pharyngeal airway [33]. Due to the increased risk of snoring with
excess bulky or fat tissue, snoring is more prevalent in overweight men than non-overweight
men [33]. Exaggerated length of the soft palate and uvula narrows the opening of airflow
between the nose and the throat, which results in negative pressure on the pharyngeal airway
during inspiration [33].
Snoring, and the irregular breathing associated with OSA, has a tendency to worsen with
age [34]. Age is an important risk factor in OSA, with the highest prevalence occurring in
middle-aged adults [35]. Other risk factors of OSA include witnessed gasping, obesity, excess
adiposity, enlarged neck size, male gender, crowded appearing pharyngeal airway, and increased
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blood pressure. All of these risk factors put one at higher risk for OSA and subsequently a higher
risk of the associated cardiovascular diseases and other morbidities [11, 16-17].
OSA has been shown to lead to autonomic dysfunction, a key factor linking OSA to other
chronic diseases [25]. Autonomic function can be assessed by fluctuations in normal heart rate
rhythm. Heart rate rhythm can be evaluated by measuring heart rate variability (HRV), which is
the variation in the time interval between heartbeats. High sympathetic drives have been
observed in individuals that experience ventilation decreases and complete breathing cessations
during sleep [23-24]. Previous scientific literature has demonstrated an association between
increased prevalence in obstructive apneas and signs of high sympathetic activity [23-24].
During sleep, individuals with OSA undergo an over activation of the sympathetic
nervous system, explained by the increased stimulation of peripheral and central chemoreflexes
as the body undergoes obstructive apnea and hypopnea episodes [36]. An indirect relationship
between oxygen and carbon dioxide occurs during bouts of obstructive apneas and hypopneas; as
oxygen saturation decreases because of partial or complete pharyngeal airway blockage, carbon
dioxide retention increases creating a disturbance in the balance of the gasses. An imbalance in
gasses alerts brain receptors to stimulate the chemoreflexes to signal the sympathetic nervous
system of the respiration acidosis [36]. Due to the cessations and decreases in ventilation, there
are consequent decreases in venous blood return to the heart, disrupting normal blood pressure in
the body and creating a disturbance in the heart’s normal autonomic function [37-38]. Increased
sympathetic activity acts to maintain normal blood pressure during the obstructive sleep apneas
via vasoconstriction of the muscles [37-38]. Moreover, sympathetic nervous system dominance
between the R-R heart intervals has also been evident in hypertensive individuals [25], as well as
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individuals with coronary artery disease [21-22], demonstrating the autonomic dysfunction
association between OSA, high blood pressure, and other cardiovascular problems [25].
OSA, as previously stated, is caused by airway obstruction and consequent hypoxia and
is most commonly identified with habitual and disruptive snoring. Previous studies have been
performed to evaluate the effects of airway obstruction and hypoxia on HRV, confirming the use
of HRV as a key tool in measuring and identifying autonomic dysfunction in adults [26]. These
studies consisted of measuring the HRV taken during undisturbed supine rest during a daytime
awake period for 10 minutes [26]. Results verified the overstimulation of the sympathetic
nervous system in OSA patients by revealing an increased ratio of low to high frequency in the
R-R heart intervals [26].
Purpose
HRV analysis had shown to be an effective screening tool in clinically diagnosed adult
OSA patients [26], which inferred that the accuracy of the HRV measurements may have also
been a powerful representative of indicating onset, not yet identified OSA in college aged
snoring subjects. An objective of this study was to determine connections between heart rate
imbalances and young snoring subjects to identify those at heightened risk for developing OSA
by analyzing individual heart rate oscillation between beat to beat intervals and utilizing the
knowledge that over stimulation of the sympathetic tone in HRV was seen in OSA patients. The
goal of this study was to examine the differences in HRV between young subject snorers and
non-snorers to determine the power of the HRV measure as an early marker of sleep disorders.
The hypothesis of this study was that heightened sympathetic activity in HRV
measurements would be seen in the subjects that were constant snorers, as snoring has shown to
be the predominant risk factor of OSA, when compared to the subjects that did not snore.
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Establishing a significant relationship between sympathetic overdrives and snoring individuals
would help to verify HRV analysis as an appropriate tool in assessing the risk of OSA in a young
adult population. If HRV analysis proved to be accurate in predicting the onset of OSA in
college age persons, further measures could be taken to prevent OSA in younger individuals
before clinical diagnosis.
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CHAPTER II
Methodology
Subjects:
The study aimed to obtain a sample of 40 college-aged (ages 18-26) sedentary males
from the James Madison University and Harrisonburg community. Recruitment of subjects was
done via flyers posted on local notice boards through campus mass emails, and also via a website
which served as the research project’s information base by including explanations of the design
of the study and descriptions of the testing procedures in which subjects would participate. The
website also held actual copies of the research project study documents. The documents did not
contain any information that allowed for subject identification.
The aim of subject recruitment was to obtain a group of 20 snorers and a group of 20
non-snorers to participate in the project. Subjects were required to be sedentary individuals or
not involved in regular exercises. Physical activity levels were assessed via questionnaire to
control for potential effects of regular exercise on autonomic function. Regular exercise may
have an attenuated effect of the sympathetic drive on resting heart rate, which could result in an
increase in the R-R intervals at rest [27]. This adaptation needed to be accounted for, as it may
have corresponded with alterations in sensitivity to the autonomic system, and therefore could
have influenced HRV data [27].
Corresponding with a sedentary lifestyle, a body mass index (BMI) greater than 25 kg/m2
was also necessary to participate in the study. A BMI value is based on the ratio of an
individual’s body weight in kilograms to their body height squared in meters. The American
College of Sports Medicine (ACSM) guidelines state that a BMI exceeding the value of 25 kg/m2
is overweight and a BMI above 30 kg/m2 is considered obese [28]. Excess body weight
11

influences an individual’s risk of OSA; therefore it was crucial to have subjects of similar BMI
values. For this study, all subjects were either overweight or obese according to ACSM
guidelines. Other exclusionary criteria for the study included that subjects were not currently
smoking, taking medication, or had any significant heart or lung disease.
Pre-test:
Subjects needed to read and sign an informed consent form. This form provided subjects
with an overview of all aspects of the study including the study’s intentions, the risks and
benefits of participating, the consequences (if any) of withdrawing from the study, and the
assurance of confidentiality to the subject involved. After subjects had granted consent, they
were told to complete questionnaires on health and sleep habits.
The first questionnaire, the Health History Questionnaire (HHQ), asked about the
subject’s health history to ensure that the subject had no problematic health or medical
conditions that would have made him ineligible for the study. This questionnaire took
approximately five minutes. Following the HHQ, subjects needed to complete four additional
questionnaires, all which took approximately one to two minutes each. The first and second
questionnaires included the Berlin Questionnaire (BQ) and the STOP questionnaire, both of
which served as tools for assessing subject’s risk level for developing OSA by assessing their
snoring habits and other potential risk factors related to OSA. The STOP questionnaire asked
questions specifically related to snoring, tiredness during daytime, observed apnea, and high
blood pressure [40]. The third questionnaire, the Epworth Sleepiness Scale (ESS), assisted in
evaluating the subject’s level of EDS. EDS, as stated previously before, is one of the strongest
symptoms in identifying individuals with OSA. The last questionnaire, the International Physical
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Activity Questionnaire (IPAQ), was used to obtain comparable estimates of the subjects’
physical activity levels, which was statistically accounted for in the study.
Testing Procedure - Body Assessment:
After completing the necessary paperwork, subjects had their weight, height, waist and
neck circumferences, and body composition assessed. Body weight was measured to the closest
0.1 kg via a physician’s scale, and height was assessed to the closest 0.5 cm. Waist and neck
circumferences were also measured to the nearest 0.5 cm. Following ACSM guidelines, waist
and neck circumferences were measured using cloth tape with a spring loaded-handle in order to
limit the pressure of the squeeze on the bare skin [28].
Body composition was evaluated via Dual-energy X-ray absorptiometry (DEXA). DEXA
scan enables the researcher to assess body composition in three compartments: fat mass, lean
mass, and calcified tissue mass, which provides for a more detailed and accurate overview of
body composition than most other methods. Along with examining the total percent body fat,
DEXA scan can also be used to quantify regional visceral adiposity percentages. As stated
previously, excessive adiposity is a risk factor for developing OSA. Visceral adiposity has a
significantly greater correlation to individuals with OSA versus individuals without OSA. Hence,
a subject’s visceral adiposity is important to determine via DEXA scan in order to evaluate if the
individual does or does not have an increased risk of OSA [29].
Testing Procedure - Heart Rate Variability Assessment
Prior to assessing the subject’s HRV, resting blood pressure (RBP) was measured
according to ACSM procedures [28]. Blood pressure readings were taken at heart level, while the
subject was in a comfortable supine position with his legs uncrossed. The blood pressure cuff
bladder was large enough to cover 80% of the subject’s upper arm circumference [28].
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HRV is a relatively easy, inexpensive and non-invasive way of assessing individual
autonomic function. Variation in beat to beat intervals was correctly measured using a polar
RS800CX monitor via a simple heart rate monitor watch system [30]. Oscillation between heart
beat intervals was detected when the subject was most relaxed in order to equally match the
intervals occurring during a sleep cycle and produce the most accurate results. To enhance
relaxation, a subject was guided to lay supine in a darkened room when being assessed.
HRV, along with heart rate, was obtained by the polar RS800CX monitor over a 15
minute time period. The heart rate measured by the monitor during the last minute was recorded
as the subject’s resting heart rate value because this was the minute in which the subject felt most
relaxed during the assessment. A normal effortless adult respiration pattern consists of 12
breaths per minute, therefore an audible metronome was synchronized to sound at 12 beats per
minute to try to best equalize this breathing pattern and control for any respiration effect on HRV
variables.
Testing Procedure: Actigraph Sleep Assessment
After the HRV data had been recorded, each subject was given an Actigraph
accelerometer (GT-3X plus). The subject was told to record the time that he went to bed and the
time that he awoken. The subject wore the Actigraph accelerometer at night while he slept to
measure his sleep patterns and store any movement during his sleep. The device was worn
properly on the non-dominant wrist; due to the small size and light weight of the device, it did
not cause any pain or discomfort to the wrist. An Actigraph accelerometer had shown to be very
reliable in measuring the sleep variability of periodic sleeping periods or waking periods during
an entire night’s sleep cycle. Thus, the Actigraph accelerometer was used to provide practical,
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obtainable information that no other sleep detective strategies could, such as individual recall
[31].
Statistical Analysis:
Variables between groups were compared using an independent sample t-test, and a pvalue less than 0.05 was considered statistically significant data. Variables that were not
normally distributed were log transformed prior to statistical analysis. Normalized LF (LFnu)
was calculated as LFnu = LF/(TP-VLF)*100 and normalized HF (HFnu) was calculated as HFnu
= HF/(TP-VLF)*100. Any significant differences found in terms of oscillation between R-R
heart intervals with a dominant override of the sympathetic tone to the parasympathetic tone in
snorers versus non snorers would be indicative of a correlation between snorers and heightened
risk of onset OSA, considering the similar HRV patterns seen in OSA patients.
Timeline:
Recruitment of subjects began in September at the start of the 2013 fall semester. The
recruitment continued throughout the fall semester and ended at the start of the following 2014
spring semester. If the goal of obtaining 40 sedentary male college student subjects was reached
before that point, then the recruitment process would have ended earlier than proposed. In order
to be pre-tested and tested, each subject reported to the Human Performance Laboratory in
Godwin 209. The pre-test and test was administered on the same day and lasted no longer than
one hour. The subject culminated his study participation when he returned the Actigraph
accelerometer device to the Human Performance Laboratory the next consecutive day. The
Actigraph accelerometer device was used for data download and analysis. The data collection
was completed by January 2014, and the completion of the following statistical analysis of the
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data was completed soon after. The completion research project due date was set for April 10th,
2014.
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Chapter III
Manuscript
Heart Rate Variability in Habitual College-aged Snorers
Abstract
Purpose Snoring is the primary, most distinguishable symptom of Obstructive Sleep Apnea
(OSA). Increased activation of the sympathetic tone is also consistently identified in adults with
clinically diagnosed OSA. We compared heart rate variability (HRV) in snoring and non-snoring
college-aged subjects to assess any HRV alterations between groups that could potentially
signify an early marker for developing OSA.
Methods 23 male snorers and 7 male non-snorer subjects were studied. The HRV variables in the
R-R heart intervals were compared between the groups via obtaining heart rate from the polar
RS800CX monitor and performing an analysis using an independent sample t-test. All subjects
were of similar age, body composition, and physical fitness.
Results HRV was not significantly reduced in snoring subjects compared to non-snoring
subjects. Age was significantly correlated to pNN50 (r=-0.48, p=0.01), RMSSDLog (r=-0.45,
p=0.01), HFLog (r=-0.49, p=0.01), Log LF/HF Ratio (r=0.53, p=0.00), LFnu (r=0.50, p=0.01),
and HFnu (r=-0.50, p=0.01).
Conclusion HRV alterations of increased sympathetic tone to parasympathetic tone are not
significantly associated with young snorers. Increased age is correlated to elevated imbalance in
HRV, most likely due to sympathetic build up over time as a result of increased progression of
the sleep disorder. The HRV measure may be a useful indicator of diagnosed OSA in middleaged adults, but not a powerful indicator of onset OSA in younger individuals because they are at
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too early of a point in potential progression of the disorder to elicit any significant physiological
changes.
Keywords: snoring, heart rate variability, sympathetic tone, obstructive sleep apnea
Introduction
Obstructive sleep apnea (OSA) is the dominant sleep disordered condition in America
[32], characterized by repetitive cessations or decreases in ventilation during an individual’s
sleep cycle due to intermittent bouts of partial (hypopnea) or total collapse (apnea) of the
pharyngeal airway [1]. Obstructive apneic and hypopnea episodes result in hypoxia and an
inadequate amount of oxygen in the blood, which could lead to severe physiological damage.
Diagnosis of OSA is established with five or more episodes of obstructive apnea or hypopnea per
hour of sleep, along with encountering strong symptoms of excessive daytime sleepiness (EDS)
[32] as a consequence of sleep deprivation caused by the obstructive disturbances [39]. A
definitive diagnosis of OSA most often requires a nighttime polysomnography, or an overnight
stay at a laboratory where numerous physiological variables related to sleep staging, respiration,
and snoring are recorded throughout the night via an electroencephalogram, electromyogram,
and an electrooculogram [32]. The physiological variables studied include breathing flow,
breathing effort, oxygen saturation levels, and electrical activity of the brain, muscles, and eyes
[32]. Having OSA is detrimental to one’s health in such that a stress reaction is developed as a
result of constant sleep restriction, and a number of comorbidities are associated with the
disorder including cardiovascular diseases (coronary artery disease, congestive heart failure,
stroke, atrial fibrillation) [12], metabolic syndrome, hypertension, and diabetes mellitus [2-15].
Autonomic dysfunction, specifically an overdrive of the sympathetic nervous system
(SNS), is a principal consequence of OSA. Heightened sympathetic drive can be explained by
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increased stimulation of peripheral and central chemoreflexes as carbon dioxide increases and
oxygen saturation decreases repeatedly during the night as a result of apnea and hypopnea events
[36]. Elevated SNS has been observed at rest in individuals with OSA [23-24]. Increased
sympathetic activity via vasoconstriction of the muscles is also a response of the body to
maintain normal blood pressure in circumstances of decreased venous blood return to the heart
during obstructive sleep apneas [37-38]. Fluctuations in normal heart rate rhythm can be assessed
by evaluating the variation in the time interval between heartbeats via heart rate variability
(HRV) analysis. HRV analysis has been validated as a measure to evaluate autonomic function
in adults and has verified that HRV is altered and most likely reduced in OSA patients, clinically
meaning that there is less balance between the parasympathetic and sympathetic tone with an
overstimulation of the SNS in OSA adults [26].
Snoring is a common risk factor of OSA [18-20] and occurs as a response to a reduction
in airflow to the nose or mouth during sleep. The reduction in airflow in the pharyngeal airway is
due to anatomical factors including relaxed oral muscle which permits the falling of tongue and
throat muscles back into the airway [33], bulky throat tissue compromising space in the airway
[33], and an exaggerated length of the soft palate and uvula which narrows the opening of
airflow between the nose and the throat creating negative pressure in the airway [33]. Other
common signs that raise the risk of OSA include older age, witnessed gasping, obesity, excess
adiposity, enlarged neck size, male gender, crowded appearing pharyngeal airway, and increased
blood pressure [11, 16-17].
Snoring is a serious risk factor for OSA, and a likely early sign of the development of
OSA. Habitual and disruptive snoring can result in poor sleep quality as well as major
disturbances in sleeping patterns, including the extreme breathing pauses and cessations
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experienced in OSA patients [33]. Looking at younger snorers to see if there are any initial signs
of altered autonomic function compared to younger non snorers will help establish if autonomic
dysfunction is also an early risk factor for OSA.
HRV measurements are an effective screening tool in clinically diagnosed adult OSA
patients [26], which led to the assumption that they may be just as effective in indicating early
signs of potential OSA in young individuals. The goal of the study was to examine the
differences in HRV variables between college age snorers and non-snorers to determine if
autonomic function is altered and a potential early sign of the development of OSA. Establishing
a strong relationship between heightened sympathetic activity and snoring would help to infer
the HRV measure as an appropriate tool in assessing the risk for young persons in developing
OSA.
Materials and Methods
Subjects
Thirty college-aged males from the James Madison University and Harrisonburg
community participated in the study. The sample consisted of 23 snorers and 7 non-snorers.
Subjects were not engaging in regular exercise in order to control for potential effects of
attenuated sympathetic drive on resting heart rate that could result from exercise [27]. To
account for similarities in excess body weight that could influence one’s risk for developing
OSA, subjects were required to be overweight, defined by the ACSM guidelines as having a
body mass index (BMI) greater than 25 kg/m2 [28]. Further inclusionary criteria for participation
in the study included that subjects were not currently smoking, taking medication, or had any
significant heart or lung disease.
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Pre-test
Subjects needed to read and sign an informed consent form regarding the study’s
intentions, risks and benefits of participating, the consequences of withdrawing, and the
assurance of confidentiality to the subject involved. After consent was granted, the Health
History Questionnaire (HHQ) was to be completed followed by the Berlin Questionnaire (BQ)
and a questionnaire related to snoring, tiredness, observed apnea, and blood pressure (STOP).
The HHQ assessed the subject’s health and medical conditions, while the latter two evaluated the
subject’s extent of snoring and other OSA related risk factors. The third and fourth
questionnaires to be completed were the Epworth Sleepiness Scale (ESS) and the International
Physical Activity Questionnaire (IPAQ). The former assessment evaluated the subject’s level of
EDS and the latter was used to obtain comparable estimates of the subjects’ physical activity
levels that were statistically accounted for.
Evaluation of Body Composition
After completing the necessary paperwork, subjects had their weight, height, waist and
neck circumferences, resting blood pressure, and body composition (via the Dual-energy X-ray
absorptiometry (DEXA)) assessed. All testing procedures strictly followed the ACSM guidelines
[28].
Evaluation of Heart Rate Variability
Heart rate variability measures consisted of time-domain parameters as well as
frequency-domain parameters. A time-domain HRV parameter measure corresponding to
parasympathetic function included RMSSD, which is the square root of the mean of the squares
of differences between continuous RR intervals [42]. Time-domain HRV parameter measures
corresponding to both sympathetic and parasympathetic function included SDNN, which is the
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standard deviation of all normal RR intervals, and pNN50, or the percentage of differences
between successive RR intervals greater than 50 milliseconds [42]. A frequency-domain HRV
parameter measure that reflected both parasympathetic and sympathetic activity was total power
(TP), or the energy in the heart period power spectrum of all RR intervals from 0 to 0.40 Hz [42].
Further frequency domain HRV parameter measures included very low frequency (VLF), low
frequency (LF), and high frequency (HF) powers, which are the energy in the heart period power
spectrum between 0.003 and 0.04 Hz, 0.04 and 0.15 Hz, and 0.15 and 0.40Hz, respectively [42].
The LF/HF ratio, or the ratio of low to high frequency power, was also a frequency-domain HRV
parameter measure. HF corresponds to parasympathetic activity and VLF, LF, and the LF/HR
ratio correspond to sympathetic activity [42].
Heart rate variation in beat to beat intervals was measured using a polar RS800CX
monitor via a simple heart rate monitor watch system [30] over a 15 minute time period while
the subject was lying supine in a dark room. Data used for analysis pertaining to oscillation
between heart beat intervals was taken from the last five minutes of the assessment when the
subject was most relaxed. An audible metronome was used to synchronize to sound at 12 beats
per minute to equalize the normal adult breathing pattern and control for any respiration effect on
HRV variables.
Statistical Analysis
Heart rate variables between snoring and non-snoring groups were compared using an
independent sample t-test, and a p-value less than 0.05 was considered statistically significant
data. Variables that were not normally distributed were log transformed prior to statistical
analysis. Normalized LF (LFnu) was calculated as LFnu = LF/(TP-VLF)*100 and normalized
HF (HFnu) was calculated as HFnu = HF/(TP-VLF)*100.
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Results
Baseline characteristics did not differ in age, body composition variables, and physical
fitness between subjects (Table 1). There were 6 subjects who reported they snore only 1 day per
week, 11 subjects who reported that they snore 2 to 4 days per week, and 6 subjects who reported
that they snore 5 days or greater per week (Table 2).
The HRV analysis revealed no significant differences in HRV variables between snoring
group and non-snoring group (Table 3). Although there were no significant differences between
the non-snoring subjects and the snoring subjects, age was significantly correlated (p < 0.05)
with particular HRV variables (Table 4). The HRV variables include pNN50 (r=-0.48, p=0.01),
RMSSDLog (r=-0.45, p=0.01), HFLog (r=-0.49, p=0.01), Log LF/HF Ratio (r=0.53, p=0.00),
LFnu (r=0.50, p=0.01), and HFnu (r=-0.50, p=0.01).
Discussion
Results from the current study show that no significant differences were found in patterns
of HRV between snoring and non-snoring subjects. This indicates that in our group of wellmatched subjects for age, body composition variables, and physical fitness levels, snoring did not
appear to have an impact on HRV. Moreover, no further significant differences were identified
when running the analysis excluding the 1 day per week snorers.
Although our findings do not reveal clear evidence of impact of snoring on HRV, snoring
has previously shown to impact HRV in non-apneic middle-aged adults by simultaneously
enhancing brain stem activity via inputs from mechanoreceptors [35], metabolic receptors [25,
21], and upper airway receptors [22,31]. These receptors stimulate the peripheral and central
chemoreflexes to elevate SNS activity when the body experiences decreases in oxygen saturation
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[36, 46]. Reductions in oxygen saturation can be due to the partial or complete pharyngeal
airway blockages associated with snoring [36, 46].
Potential reasons that our results did not validate HRV alternation in snoring individuals
compared to non-snoring individuals could be due to the tendency of snoring to worsen with age
as well as the higher prevalence of snoring in a middle-aged population compared to a younger
college-aged population [34]. Thus, college-aged snorers assessed in our current study may not
have yet progressed to the level of snoring, in terms of intensity and duration, as their middleaged counterparts. The greater amount of apneas and hypopnea episodes accumulated over time
from young adulthood to middle-aged adult years, the more dominant the sympathetic tone
becomes, leading eventually to a diminished HRV [40]. Young subjects from our current study
many not have yet built up the necessary amount of enhanced brain stem activity and
corresponding sympathetic activity resulting from long term snoring to elicit any substantial
changes or reductions in HRV.
Moreover, previous literature found that HRV, with or without snoring symptoms, is
reduced in middle-age adults [43]. This means that effects of HRV are age dependent, and as an
individual develops from young adulthood to middle-aged years, the balances between the
sympathetic tone and the parasympathetic tone become increasingly weakened. This theory
offers further support to why HRV changes were not significantly evident in our younger sample
population of our current study; simply because these chosen subjects were potentially too young
in age to provoke any physiological deviations in heart rate that typically come in response to
getting older.
Furthermore, when performing a Pearson correlation matrix in our current study, results
revealed that age was significantly associated with HRV variables pNN50, RMSSDLog, HFLog,
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Log of LF/HF Ratio, LFnu, and HFnu. This demonstrates more distinct HRV imbalances in our
subjects as age increased, as clear correlations were found between increasing age and
decreasing variation in the R-R heart intervals as well as increasing age and increasing activation
of the SNS. Hence, college-aged subjects that had the primary risk factor of snoring who were
sampled in our procedure may have been too young and likely way too early in their progression
of possible OSA development to display any substantial physiological adaptations from the
disorder. Based on our results, it appears possible that with increased age, the more susceptible
one is to see heart rate relate to snoring in terms of noticeable signs of decreased HRV and
elevated SNS.
Previous literature supports this analysis by finding that the non-balance in HRV found in
individuals with OSA becomes more extreme over time [40]. One study compared the R-R heart
interval patterns of moderate sleep apneic individuals to the R-R interval patterns of those who
had developed further, more severe sleep apnea over time [40]. The sympathetic tone becomes
more exaggerated and sleep apnea becomes more severe over time as a result of the continuous
apneas and hypoxias that occur during sleep in individuals with OSA [40]. The results of this
study showed that the LF/HF ratio was higher in the severe sleep apnea group compared to the
moderate sleep apnea group, and a heightened LF/HF ratio corresponds to larger sympathetic
activity [40]. This explains that with greater progression and worsening of the disorder, the
greater was the dominance of the SNS [40]. Therefore, it is possible that even though the
college-aged subjects assessed in our current study had a number of risk factors for OSA, this
population may not yet be far enough advanced in the development of the potential disorder to
display any signs of overriding sympathetic activity and corresponding HRV reduction.
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Furthermore, another study found similar findings in that the more severe and far along
the sleep disorder had become, the more increased the sympathetic burst frequency and the more
decreased the balance in the R-R heart intervals [41]. This study assessed HRV of muscle
sympathetic nerve activity and the R-R heart intervals in 15 patients with moderate-to-severe
OSA, 18 patients with mild OSA, and 16 healthy control subjects [41]. When comparing the
moderate-to-severe OSA group to the mild OSA group, the former had a higher LF-to-HF ratio,
signifying a greater dominance of the SNS compared to the PNS [41]. The moderate-to-severe
OSA group also showed to have a lower normalized HF variability, meaning a lower overall tone
of the PNS when compared to the mild OSA group [41]. Patients with mild sleep apnea still had
evident abnormalities in their HRV, but these abnormalities were much less pronounced than
those of the moderate-to-severe OSA group [41]. This study offers support to our current study
in providing evidence that if OSA has not yet developed to a mild, moderate, or a severe level
(which it has not in our young population sample), than HRV alterations will not be very
prominent or may not be noticed at all, which was the case for our study.
The limitations to our study included a small sample of control non-snorers to compare to
the snorer group. With a larger sample, there would have been a greater chance in finding any
statistical significant differences in the heart rate analysis data. Another limitation included that
the amount a subject snores was self-reported by college age students. It is less likely that this
age group has someone, for example a spouse, whom would be able to give them an accurate
accounting of their snoring frequency.
To summarize, our hypothesis of the study, which stated that heightened sympathetic
activity in HRV measurements would be seen in subjects who were snorers compared to those
that did not snore, was not supported. Hence, although HRV has shown to be a key tool in
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measuring and identifying autonomic dysfunction in adults with already clinically diagnosed
OSA [26], the analysis may not be as powerful of an indicator in identifying not yet diagnosed
OSA in college aged individuals. Solely using HRV as an early marker for the disorder may be a
disadvantage in that physiological adaptations of increased SNS activity that evolves as a
consequence of OSA over time may have not yet developed in younger persons who snore. In
conclusion, although the college-aged snorers sampled had several risk factors for OSA
including snoring, being overweight to obese, and having at risk neck circumference measures,
this population may be at too early of a point in their possible development of OSA for snoring
to elicit any valuable physiological changes in terms of HRV reduction.
Manuscript References
1.Sleep-related breathing disorders in adults: recommendations for syndrome definition and
measurement techniques in clinical research. The Report of an American Academy of Sleep
Medicine Task Force.Sleep. 1999;22:667– 689.
2. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142:187–
197.
3. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J
Am Coll Cardiol. 2003;41:1429 –1437.
4. Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002; 360:237–245.
5. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac
and vascular disease. JAMA. 2003;290:1906–1914.
6. Bradley TD, Floras JS. Sleep apnea and heart failure: part I: obstructive sleep apnea.
Circulation. 2003;107:1671–1678.
7. Caples SM, Garcia-Touchard A, Somers VK. Sleep-disordered breathing and cardiovascular
risk. Sleep. 2007;30:291–303.
8. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med.
2001;164:2147–2165.
9. Pack AI. Advances in sleep-disordered breathing. Am J Respir Crit Care Med. 2006;173:7–15.
10. Veasey SC. Molecular and physiologic basis of obstructive sleep apnea. Clin Chest Med.
2003;24:179 –193.
11. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past,
present and future: report of a workshop from the National Center on Sleep Disorders Research
and the National Heart, Lung, and Blood Institute. Circulation. 2004;109:951–957.
12. Wolk R, Kara T, Somers V. Sleep-disordered breathing and cardiovascular disease.
Circulation. 2003;108:9 –12

27

13. McNicholas WT, Bonsigore MR. Management Committee of EU COST ACTION B26.
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic
mechanisms and research priorities.
Eur Respir J. 2007;29:156 –178.
14. Kapa S, Sert Kuniyoshi FH, Somers VK. Sleep apnea and hypertension: interactions and
implications for management. Hypertension. 2008;51:605-608.
15. Lopez-Jimenez F, Sert Kuniyoshi FHS, Gami A, Somers VK. Obstructive sleep apnea:
implications for cardiac and vascular disease: part II: contemporary reviews in sleep medicine.
Chest. 2008;133:793–804.
16. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep
apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur
Heart J. 2004;25:735–741.
17. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. “Syndrome Z”: the
interaction of sleep apnoea, vascular risk factors and heart disease. Thorax. 1998;53(suppl
3):S25–S28.
18. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea.
Am J Respir Crit Care Med 1998;157:1098–1103.
19. Peker Y, Hedner J, Kraiczi H, Lo¨th S. Respiratory disturbance index: an independent
predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81–86.
20. Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke 2001;32:1271–
1278.
21. St Croix CM, Morgan BJ, Wetter TJ, Dempsey JA: Fatiguing inspiratory muscle work
causes reflex sympathetic activation in humans. J Physiol 2000, 529:493-504.
22. Bachoo M, Polosa C: Properties of a sympatho-inhibitory and vasodilator reflex evoked
by superior laryngeal nerve afferents in the cat. J Physiol 1985, 364:183-198
23. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting
sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993;103:1763–1768.
24. Eisenberg E, Zimlichman R, Lavie P. Plasma norepinephrine levels in patients with sleep
apnea syndrome. N Engl J Med 1990;322:932–933.
25. Dempsey JA, Sheel AW, St Croix CM, Morgan BJ: Respiratory influences on
sympathetic vasomotor outflow in humans. Respir Physiol Neurobiol 2002, 130:3-20
26. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered
cardiovascular variability in obstructive sleep apnea. Circulation 1998;98:1071–1077.
27. Sandercock GR, Bramley PD, Brodie DA. Effects of exercise on heart rate variability:
inferences from meta-analysis. Med Sci Sports Exerc. 2005;37(3)433-439.
28. American College of Sports Medicine., Thompson WR, Gordon NF, Pescatello LS. ACSM's
guidelines for exercise testing and prescription. 8th ed. Philadelphia: Lippincott Williams &
Wilkins; 2010.
29. Gates, G. J., Mateika, S. E., Mateika, J. H. (2005). Heart rate variability in non-apneic
snorers and controls before and after continuous positive airway pressure. BMC Pulmonary
Medicine. 5:9 doi:10.1186/1471-2466-5-9
30. Nunan D, Donovan G, Jakovljevic DG, Hodges LD, Sandercock GR, Brodie DA. Validity
and reliability of short-term heart-rate variability from the Polar S810. Medicine and science in
sports and exercise 2009;41:243-50.
28

31. Tomori Z, Widdicombe JG: Muscular, bronchomotor and cardiovascular reflexes
elicited by mechanical stimulation of the respiratory tract. J Physiol 1969, 200:25-49
32. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS,
Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, and Young T. Sleep apnea and
cardiovascular disease: an American Heart Association/American College Of Cardiology
Foundation Scientific Statement from the American Heart Association Council for High Blood
Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke
Council, and Council On Cardiovascular Nursing: In collaboration with the National Heart,
Lung, and Blood Institute National Center on Sleep Disorders Research. J Am Coll Cardiol.
2008;52(8):686-717. doi:10.1016/j.jacc.2008.05.002
33. Fairbanks, D. N. (1987). Snoring: An Overview with Historical Perspectives. Snoring and
Obstructive Sleep Apnea (pp.6-9). New York: Raven Press.
34. Catterall JR, Calverley PMA, Shapiro CM, Flenley DC, Douglas NJ. Breathing and
oxygenation during sleep are similar in normal men and women. Am Rev Respir Dis. 1985;
132:86-88.
35. Leuenberger UA, Mostoufi-Moab S, Herr M, Gray K, Kunselman A, Sinoway LI:
Control of skin sympathetic nerve activity during intermittent static handgrip exercise.
Circulation 2003, 108:2329-2335
36. Somers, V. K., D. C. Zavala, A. L. Mark, and F. M. Abboud. 1989. Contrasting effects of
hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J. Appl. Physiol.
67:2101-2106.
37. Guilleminault, C., J. Motta, F. Mihm, and K. Melvin. 1986. Obstructive sleep apnea and
cardiac index. Chest. 89:331-334.
38. Katzenberg, C., M. Olajos, E. Morkin, and S. Goldman. 1986. Effects of changes in airway
pressure on the left ventricle and left atrium of dogs. Cardiovasc. Res. 20:853-862.
39. Bittencourt, Lia Rita Azeredo et al. Excessive daytime sleepiness. Rev. Bras. Psiquiatr. 2005;
27(1):16-21. doi: 10.1590/S1516-44462005000500004
40. Doo-Heum Park, Chul-Jin Shin, * Seok-Chan Hong,† Jaehak Yu, Seung-Ho Ryu, Eui-Joong
Kim,‡ Hong-Beom Shin,‡ and Byoung-Hak Shin. (2008). Correlation between the Severity of
Obstructive Sleep Apnea and Heart Rate Variability Indices. J Korean Med Sci. 23(2):226-231.
Retrieved from http://dx.doi.org/10.3346/jkms.2008.23.2.226
41. Krzysztof Narkiewicz, MD, PhD; Nicola Montano, MD, PhD; Chiara Cogliati, MD; Philippe
J. H. van de Borne, MD, PhD; Mark E. Dyken, MD; Virend K. Somers, MD, PhD. (1998).
Clinical Investigation and Report: Altered Cardiovascular Variability in Obstructive Sleep
Apnea. Circulation. 98: 1071-1077 doi: 10.1161/01.CIR.98.11.1071
42. M. Tolga Doğru, M.D., Vedat Şimşek, M.D., Ömer Şahin, M.D., Nurtaç Özer, M.D. (2010)
Differences in autonomic activity in individuals with optimal, normal,and high-normal blood
pressure levels. Arch Turk Soc Cardiol; 38(3):182-188
43. Wang, SY., Zhang, LF., Wang, XB,. Cheng, JH. (2000). Age dependency of heart rate
variability, blood pressure variability and baroreflex sensitivity. Space Med Med Eng; 13(5):31822.

29

Table 1- Subject Characteristics
Characteristic

Snorers
(n=23)
Age (yr)
20.3 ± 1.8
2
BMI (kg/m )
29.1 ± 2.6
Waist (cm)
94.9 ± 10.3
Neck (cm)
40.2 ± 2.0
Total body fat (%)
23.4 ± 8.3
.
.
-1
MET min wk
2877.9 ± 2883.5
BMI = body mass index; MET = metabolic equivalent
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Non Snorers
(n=7)
19.7 ± 2.0
28.8 ± 3.6
89.8 ± 6.4
39.6 ± 2.4
19.1 ± 5.9
3460.4 ± 2279.4

Table 2- Subjects’ Self Reports of Snoring Frequency
Snoring Frequency
(days/week)
0
1
2-4
≥5

# of subjects that reported relevant
frequency
(n=30)
7
6
11
6
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Table 3- Heart Rate Variability Analysis Data
HRV Variable
SDNN (ms)

Snorers
(n=23)
81.4 ± 38.6

Non Snorers
(n=7)
81.7 ± 27.1

pNN50 (%)

13.2 ± 9.7

18.7 ± 12.1

RMSSDLog

1.7 ± 0.3

1.8 ± 0.3

TPLog

3.8 ± 0.4

3.8 ± 0.4

VLFLog

3.4 ± 0.5

3.5 ± 0.5

LFLog

3.2 ± 0.4

3.2 ± 0.3

HFLog

3.0 ± 0.5

3.1 ± 0.5

Log LF/HF Ratio

2.2 ± 0.3

2.1 ± 0.5

LFnu

60.0 ± 16.6

54.1 ± 23.7

HFnu

40.0 ± 16.6

45.7 ± 23.7

HRV = heart rate variability; SDNN = standard deviation of all normal R-R heart intervals;
pNN50 = the percentage of differences between successive R-R heart intervals greater than 50
ms; RMSSDLog = log transformed square root of the mean of the squares of differences between
continuous R-R heart intervals; TPLog = log transformed total power; VLFLog = log
transformed very low frequency; LFLog = log transformed low frequency, HFLog = log
transformed high frequency; Log LF/HF Ratio = log transformed low frequency to high
frequency ratio; LFnu = low frequency normalized units; HFnu = high frequency normalized
units

32

Table 4- Pearson Correlation Matrix of Age and HRV Variables among all Subjects
HRV Variable

P-value
(2-tailed)

SDNN (ms)

Pearson Correlation (r) w/
Subject Age
(n=30)
-0.34

pNN50 (%)

-0.48*

0.01*

RMSSDLog

-0.45*

0.01*

TPLog

-0.35

0.01

VLFLog

-0.28

0.13

LFLog

-0.17

0.37

HFLog

-0.49*

0.01*

Log LF/HF Ratio

0.53*

0.00*

LFnu

0.50*

0.01*

HFnu

-0.50*

0.01*

0.06

*Correlation is significant (p < 0.05)
HRV = heart rate variability; SDNN = standard deviation of all normal R-R heart intervals;
pNN50 = the percentage of differences between successive R-R heart intervals greater than 50
ms; RMSSDLog = log transformed square root of the mean of the squares of differences between
continuous R-R heart intervals; TPLog = log transformed total power; VLFLog = log
transformed very low frequency; LFLog = log transformed low frequency, HFLog = log
transformed high frequency; Log LF/HF Ratio = log transformed low frequency to high
frequency ratio; LFnu = low frequency normalized units; HFnu = high frequency normalized
units
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Appendix A: Email Recruitment Statement
Sleep Research at James Madison University
Researchers at James Madison University are recruiting young males to be subjects in a study on
how sleep affects health. Good candidates are:
-

18 – 26 years old
NOT regular exercisers (do not exercise 3 or more times per week)
Not currently smoking
Are without significant heart or lung disease
Not currently taking medications
Have a body mass index greater than 25 [BMI = weight in kg / (height in meters)2].

If you have been told that you snore, you may be a particularly good candidate. The study would
require subjects to complete several questionnaires about your health and sleep habits, wear a
small device for one night while sleeping, and a complete body composition assessment.
Subjects will receive a report on their health status including percent body fat and sleep quality.
If interested please contact us at 908-328-4244 or at sleepstudy.jmu@gmail.com.
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Appendix B: Flyer Recruitment Statement
James Madison University Kinesiology Department
Subjects needed for a study on the impact of sleep on health

Eligibility








18 – 26 years old men
NOT regular exercisers (defined as 3 or more times per week)
Not currently smoking
Are without significant heart or lung disease
Not currently taking medications
Have a body mass index greater than 25 [BMI = weight in kg / (height in meters)2].
SNORERS also wanted!

Study Requirements





Complete questionnaires on health and sleep habits
Wear small device on your wrist for one night while you sleep
Body composition measurement
Ultrasound imaging of blood vessels in your neck and arm

Subjects Receive



Report on body composition (% fat)
Report on sleep quality

To Enroll in the Study



Call (908) 328-4244
Email sleepstudy.jmu@gmail.com
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Appendix C: Informed Consent
James Madison University
Department of Kinesiology
Informed Consent
Purpose
You are being asked to volunteer for a research project conducted by Dr. Trent Hargens and
exercise kinesiology student Erica Searfoss from James Madison University studying the
association of snoring with autonomic dysfunction in at-risk for sleep apnea young men.
The primary goals of this study is to examine whether the physiological alterations that are a
result of habitual snoring in diagnosed obstructive sleep apnea (OSA) adults are evident in
snoring at-risk not yet diagnosed younger individuals. The physiological alterations include
reduced heart rate variability and increased sympathetic dominance.
Experimental Procedures
You will be asked to visit the Human Performance Laboratory (Godwin 209) 2 times, 1 – 2 days
apart. Your total time commitment for participation in this study will be approximately 1 hour.
In addition, you will be asked to wear a device on your wrist for 1 night, while you sleep. This
will be done in your own home. Detailed information on each visit is provided below:
Visit 1
Before any test is given, you will be asked to complete a prescreening and an informed consent
form, to insure that you meet the study criteria and that you do not have any factors that would
disqualify you from participation. Upon completion of the informed consent, you will be asked
to complete a short health history questionnaire providing information about your characteristics
and health. You will then be asked complete 4 standardized questionnaires about snoring and the
quality of your sleep, daytime sleepiness, risk for OSA, and current physical activity levels.
You will then have your height, weight, waist circumference and neck circumference measured.
After that, your body composition will be analyzed via a Dual-energy x-ray absorptiometer
(DEXA). The DEXA scan will allow us to measure your percent body fat and the mineral
content and density of your bones. The DEXA is much like an X-ray machine. The DEXA will
scan your entire body very slowly; so, you will need to lie on a table without moving for almost
10 minutes, while the DEXA is passed over your entire body. You will feel no discomfort
associated with this test.
Following the DEXA scan, we will ask that you wear a heart rate monitor while lying down in a
darkened room for 15 minutes to get measures of your heart rate.
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At the end of this first visit you will also be instructed on the proper use procedures for wearing
an accelerometer to monitor your sleep for 1 night. An accelerometer is a small device that is to
be worn on your wrist while in bed. You will also be asked to record the time you go to bed and
the time you get up the following morning.
Visit 2
One to two days after Visit 1, you will be asked to return to Godwin 209 to return the
accelerometer.
Risks
There are no risks associated with wearing an accelerometer. Also, there is no risk associated
with heart rate, height, weight, and waist and neck circumference measures. A measurement
with associated risks includes the DEXA scan.
The amount of radiation that you will receive in the DEXA exam is less than the amount
permitted by the Food and Drug Administration (FDA) per year. The amount you will receive is
equal to 1/20 of a chest x-ray or no greater than you normally receive each day from your
surroundings over the course of a week.
Benefits
There is no guarantee that you will get any benefit from taking part in this study. Benefits may
include knowledge about your health status. You will receive information on your body
composition, including percent body fat and bone mineral density, and an assessment of your
sleep quality and risk for sleep apnea.
Inquiries
If you have any questions or concerns or you would like to receive a copy of the final aggregate
results of this study, please contact Dr. Trent Hargens at hargenta@jmu.edu or (540) 568-5844.
In the case of any immediate concerns or adverse reactions during the study, contact Dr. Hargens
on his cell phone (540) 810-1310.
Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
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Confidentiality
All data and results will be kept confidential. You will be assigned an identification code. At no
time will your name be identified with your individual data. The researcher retains the right to
use and publish non-identifiable data. All data will be kept secured in a locked cabinet. Final
aggregate results will be made available to participants upon request.
Freedom of Consent
Your participation is entirely voluntary. You are free to choose not to participate. Should you
choose to participate, you can withdraw at any time without consequences of any kind.
I have read this consent form and I understand what is being requested of me as a participant in
this study. I freely consent to participate. I have been given satisfactory answers to my
questions. The investigator provided me with a copy of this form. I certify that I am at least 18
years of age.

________________________________
Name of Subject (Printed)

________________________________
Name of Subject (Signed)

________________________________
Date

__________________________________
Name of Researcher (Printed)

__________________________________
Name of Researcher (Signed)

__________________________________
Date
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Appendix D: Subject Prescreening Information
Please complete the Following:

Age (yrs):

Height (inches):

Weight (lbs):

Average Exercise Habits over the Past 2 Months:

Avg. # days of exercise per week:

Avg. # of days of aerobic exercise per week:

Avg. # of days of resistance exercise per week:

Do you currently use medications of any kind?

Have you previously been diagnosed with a heart or lung disease?

Do you have diabetes?
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Snoring
Do you snore?

If yes, do you snore: (circle one)

1 Day per week

2-4 Days per week

5 or greater Days per week
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Appendix E: Health History Questionnaire
HEALTH HISTORY QUESTIONNAIRE
TODAY’S DATE _______________________
NAME ______________________ AGE______ DATE OF BIRTH ___________________
ADDRESS
__________________________________________________________________________
Street

City

State

TELEPHONE: HOME/ CELL _________/ __________

Zip

E-MAIL ADDRESS _____

Person to contact in case of an emergency _________ Phone _________ (relationship) _______

Have you ever been diagnosed with cardiovascular disease?

YES

NO

Have you ever been diagnosed with musculoskeletal disease?

YES

NO

Have you ever had any heart problems?

YES

NO

Have you ever had Asthma?

YES

NO

Have you ever been told by a doctor you should not exercise? YES

NO

Are you taking any Prescription (include birth control pills) or Non-Prescription medications?
Yes No
For each of your current medications, provide the following information:
MEDICATION Dosage- times/ day

Time taken

Years on medication

Reason for

Taking
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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ACTIVITY LEVEL EVALUATION
What is your occupational activity level?

Sedentary

Light

Moderate

Do you currently engage in vigorous physical activity on a regular basis?

Heavy

Yes

No

If so, what type(s)? _______________________ How many days per week? __________
How much time per day?

<15 min

15-30 min

30-45 min

>60 min

Do you engage in any recreational or leisure-time physical activities on a regular basis?
Yes

No

If so, what activities?
__________________________________________________________________
On average: How often? ________ times/week;

for how long? ____________ time/session

Do you ever have an uncomfortable shortness of breath during exercise or when doing activities?
Yes

No

Do you ever have chest discomfort during exercise?
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Yes

No

Appendix F: Epworth Sleepiness Scale
Subject ID______

Name_____________________

Date Completed ____/____/____

This questionnaire asks you to indicate the chances of you becoming drowsy during hours of the
day that you are not in bed sleeping. “How likely are you to doze off or fall asleep in the
following situations?”

Use the following scale and indicate the most appropriate number for each situation.

0 = would never doze
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing

Situation

Chance of Dozing

1.

Sitting and reading

_____

2.

Watching T.V.

_____

3.

Sitting, inactive in a public place
(ex. Theatre or meeting)

4.

_____

As a passenger in a car for
an hour without a break

_____
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5.

Lying down to rest in the afternoon
when circumstances permit

_____

6.

Sitting and talking with someone

_____

7.

Sitting quietly after a lunch without alcohol

_____

8.

In a car, while stopped for a few minutes
in the traffic

Sum of Scores, items 1-8

_____

(staff use only)

_____/24

44

Appendix G: Berlin Questionnaire
Berlin Questionnaire
Subject ID______ Name______________________________ Date Completed ____/____/____
Height (cm) ___________

Weight (kg) _________

Please choose the correct response to each question:
Category 1
1. Do You Snore?
☐ a. Yes
☐ b. No
☐ c. Don’t know

If you snore:
2. Your snoring is:
☐ a. Slightly louder than breathing
☐ b. As loud as talking
☐ c. Louder than talking
☐ d. Very loud – can be heard in
adjacent rooms

3. How often do you snore?
☐ a. Nearly every day
☐ b. 3-4 times a week
☐ c. 1-2 times a week
☐ d. 1-2 times a month
☐ e. Never or nearly never
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Age _____

4. Has your snoring every bothered
other people?
☐ a. Yes
☐ b. No
☐ c. Don’t Know

5. Has anyone noticed that you quit
Breathing during your sleep?
☐ a. Nearly every day
☐ b. 3-4 times a week
☐ c. 1-2 times a week
☐ d. 1-2 times a month
☐ e. Never or nearly never

Category 2

6. How often do you feel tired or fatigued after you sleep?
☐ a. Nearly every day
☐ b. 3-4 times a week
☐ c. 1-2 times a week
☐ d. 1-2 times a month
☐ e. Never or nearly never
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7. During your waking time, do you feel tired, fatigued or not up to par?
☐ a. Nearly every day
☐ b. 3-4 times a week
☐ c. 1-2 times a week
☐ d. 1-2 times a month
☐ e. Never or nearly never

8. Have you ever nodded off or fallen asleep while driving a vehicle?
☐ a. Yes
☐ b. No

If yes:
9. How often does this occur?
☐ a. Nearly every day
☐ b. 3-4 times a week
☐ c. 1-2 times a week
☐ d. 1-2 times a month
☐ e. Never or nearly never

Category 3
10. Do you have high blood pressure?
☐ a. Yes
☐ b. No
☐ c. Don’t Know
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Appendix H: STOP Questionnaire
Stop Questionnaire
Subject ID______ Name______________________________ Date Completed ____/____/____

Height (Inches) ___________

Weight (lbs) _________

Age _____

Neck Circumference (cm) ____________

The STOP Test consists of four questions:

1. Snoring
Do you snore loudly (louder than talking or loud enough to be heard through closed door)?
Yes No
2. Tired
Do you often feel tired, fatigued or sleepy during the day?

Yes No

3. Observed
Has anyone observed you stop breathing during your sleep?

Yes No

4. Blood Pressure
Do you have or are you being treated for high blood pressure?

High risk of OSA: answering yes to two or more questions
Low risk of OSA: answering yes to less than two questions
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Yes No

Appendix I: International Physical Activity Questionnaire
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